197 related articles for article (PubMed ID: 15103218)
21. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
22. Misleading terms in Anderson-Fabry disease.
Weidemann F; Strotmann JM; Breunig F; Niemann M; Maag R; Baron R; Eggert AO; Wanner C
Eur J Clin Invest; 2008 Mar; 38(3):191-6. PubMed ID: 18257782
[TBL] [Abstract][Full Text] [Related]
23. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
24. Clinical spectrum of Anderson Fabry disease in a Romanian family.
Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
[TBL] [Abstract][Full Text] [Related]
25. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
[TBL] [Abstract][Full Text] [Related]
26. Subclinical optic neuropathy in Fabry disease.
Pitz S; Grube-Einwald K; Renieri G; Reinke J
Ophthalmic Genet; 2009 Dec; 30(4):165-71. PubMed ID: 19852573
[TBL] [Abstract][Full Text] [Related]
27. [Fabry disease in Italy: first epidemiologic and collaborative study].
Ricci R; Castorina M; Di Lillo M; Antuzzi D; Frustaci A; Parini R; Menni F; Furlan F; Burlina A; Burlina A; Catuogno S; Gabrielli O; Burattini I; Borsini W; Buchner S; Ferriozzi S; Spisni C; De Vito R; Di Rocco M; Aricò M; Pistone G; Bongiorno AM; Morrone A; Cavicchi C; Zammarchi E
Ann Ital Med Int; 2004; 19(4):269-75. PubMed ID: 15678707
[TBL] [Abstract][Full Text] [Related]
28. Hormonal profile and fertility in patients with Anderson-Fabry disease.
Hauser AC; Gessl A; Harm F; Wiesholzer M; Kleinert J; Wallner M; Voigtländer T; Bieglmayer C; Sunder-Plassmann G
Int J Clin Pract; 2005 Sep; 59(9):1025-8. PubMed ID: 16115176
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey.
Elliott P; Baker R; Pasquale F; Quarta G; Ebrahim H; Mehta AB; Hughes DA;
Heart; 2011 Dec; 97(23):1957-60. PubMed ID: 21890869
[TBL] [Abstract][Full Text] [Related]
30. Fabry disease: renal biopsy-proven cases from China.
Zhang SH; Liu ZH; Zeng CH; Li SJ; Chen HP; Su J; Li LS
J Nephrol; 2007; 20(6):716-26. PubMed ID: 18046674
[TBL] [Abstract][Full Text] [Related]
31. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
[TBL] [Abstract][Full Text] [Related]
32. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers.
Linthorst GE; Vedder AC; Aerts JM; Hollak CE
Clin Chim Acta; 2005 Mar; 353(1-2):201-3. PubMed ID: 15698608
[TBL] [Abstract][Full Text] [Related]
33. [Clinical courses of two male siblings on hemodialysis for Fabry disease ].
Itoh K; Tanaka M; Matsushita K; Miyamura N; Nishida K; Araki E; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2005; 47(2):121-7. PubMed ID: 15859134
[TBL] [Abstract][Full Text] [Related]
34. Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
Hegemann S; Hajioff D; Conti G; Beck M; Sunder-Plassmann G; Widmer U; Mehta A; Keilmann A
Eur J Clin Invest; 2006 Sep; 36(9):654-62. PubMed ID: 16919049
[TBL] [Abstract][Full Text] [Related]
35. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre.
Nguyen TT; Gin T; Nicholls K; Low M; Galanos J; Crawford A
Clin Exp Ophthalmol; 2005 Apr; 33(2):164-8. PubMed ID: 15807825
[TBL] [Abstract][Full Text] [Related]
36. Ocular Manifestations of Fabry Disease: Report from a Tertiary Eye Care Center in Türkiye.
Korkmaz İ; Kalkan Uçar S; Onay H; Yıldırım Sözmen E; Çoker M; Palamar M
Turk J Ophthalmol; 2024 Jun; 54(3):127-132. PubMed ID: 38940325
[TBL] [Abstract][Full Text] [Related]
37. Anderson-Fabry disease and other lysosomal storage disorders.
Nagueh SF
Circulation; 2014 Sep; 130(13):1081-90. PubMed ID: 25245844
[No Abstract] [Full Text] [Related]
38. FabryScan: a screening tool for early detection of Fabry disease.
Arning K; Naleschinski D; Maag R; Biegstraaten M; Kropp P; Lorenzen J; Hollak CE; van Schaik IN; Harten P; Zeuner RA; Binder A; Baron R
J Neurol; 2012 Nov; 259(11):2393-400. PubMed ID: 22878429
[TBL] [Abstract][Full Text] [Related]
39. Results of the screening program for Fabry disease in patients with cornea verticillata at the University Hospital of Navarre.
Fanlo P; Garralda A; Gómez-Cerezo JF; Echeverria M; López M; Heras H; Riera-Mestre A
Rev Clin Esp (Barc); 2023 Jan; 223(1):25-31. PubMed ID: 36528303
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]